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The problem of how to use financial resources beneficially in health care, despite limited budgets, 
reduced personnel, and inadequate time, goes beyond the realm of health economists (1). How do 
we use existing resources to prioritize one health program over another? Does a specific program 
provide a real and measurable improvement in terms of perceived health-related quality of life 
(HRQOL)? What decisions should we make?
In the recent years, the HRQOL index has become an asset for evaluating patient health status in 
health programs, therapies, and clinical trials (2). Created as a specific psychological construct for 
use in health contexts, the HRQOL index is now widely used and evaluated by health economists, 
epidemiologists, clinicians, and nurses. Today, the notion that health status is not only determined by 
survival or absence of disease but also closely related to quality of health is universally accepted (3, 4).
Health-related quality of life has been defined as the functional effect of a medical condition 
and/or treatment on a patient. Thus, HRQOL is a subjective and multidimensional parameter that 
encompasses physical and occupational functioning, psychological state, social interaction, and 
somatic sensation (5). Health is perceived by the person as a state that lies beyond the presence 
of a disease or the severity of a condition. HRQOL is influenced by several factors that include 
not only psychological and emotional aspects, individual behavior, and attitudes but also personal 
experiences, culture, and religious beliefs (6, 7). Owing to this subjectivity, patients with the same 
medical condition may have very different perceptions of HRQOL. For example, patients with some 
hematological conditions, such as hemophilia, may experience a good HRQOL despite having 
several disease-related complications, whereas others with the same disorder but better clinical 
conditions may perceive a poor HRQOL (8–12). Similar results have been obtained in patients with 
other chronic conditions, such as back pain (13, 14).
Evaluation of HRQOL has been encouraged over the last two decades to obtain a broader perspec-
tive of health status in patients and to identify which therapeutic choices and programs to pursue 
(15). Health economists may use the HRQOL construct as a deciding factor in applying economic 
analyses. For example, in cost-benefit, cost-effectiveness, or cost-utility analyses, HRQOL may repre-
sent one indicator for measuring effectiveness (e.g., success of a health program, specific treatment, or 
regulatory policy) (16). In this context, effectiveness may be measured as a final outcome, such as the 
number of life-years gained or number of lives saved, by applying a certain program or proposing a 
certain treatment. Alternatively, it may be measured as an intermediate outcome in a health program, 
such as the number of days lost from school or work, perceived HRQOL, treatment satisfaction, or 
psycho-emotional well-being (17).
The HRQOL construct focuses on the patient’s perceived state of health as a reference value in 
evaluating programs and making medical decisions. In this light, we wish to discuss the potential of 
the HRQOL and psychological science in a new medical paradigm that has been recently described 
as an alternative approach to the traditional paradigm of evidence-based medicine, namely, the 
value-based medicine approach.
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pSYCHOLOGiCAL pERSpECTiVE OF THE 
VALUE-BASED SYSTEM
Health systems are increasingly being burdened by enormous 
public expenditures, and health policy decisions made to contain 
costs have so far been ineffective. A new direction for facilitating 
health-care management and containing health-care costs may 
be represented by Porter’s theoretical value-based model (18, 19). 
According to this model, choices in the health context should be 
oriented toward “adding value for the patient.” Health systems 
may support interventions and choices that appear expensive 
in the short term but provide better outcomes in the long term, 
with a drastic reduction of costs and public expenditures (20).
The value-based model is different from the evidence model, 
but they are linked together. While the traditional evidence-based 
medicine often measures the improvement gained in length of 
survivorship, but generally does not measure the significance in 
terms of quality-of-life improvement, the value-based medicine 
integrates the best results of evidence-based medicine (it uses best 
evidence-based data) to a superior level of analysis by combining 
the HRQOL evaluations of patients “with a disease in concerning 
the value of an intervention” (20).
According to this perspective, it is necessary to promote 
integrated interventions that care for the whole patient, with the 
psychological aspects of care taking on increasing importance 
(21, 22). The value-based model highlights the importance of 
health outcomes, including HRQOL and patient well-being, in 
making appropriate medical decisions. Sustainable and improved 
health-care management and costs may be obtained by measur-
ing concrete patient health outcomes (patient utility) and aban-
doning evaluations of general health structure costs, which had 
been proposed by the traditional evidence-based medicine model 
(20). The value-based model proposes that health outcomes be 
measured over a longer period, and that the patient’s health 
status be compared in a comprehensive and integrated manner 
that considers all aspects of the patient’s life (i.e., physical health, 
psychological aspects, and social life). Thus, the term value can-
not be reduced to the cost of an intervention but must include a 
general evaluation of the patient’s overall well-being. Although 
this general evaluation includes HRQOL, the construct must be 
evaluated in a wider perspective together with all other health 
outcomes (e.g., utility, satisfaction, patient preferences, and level 
of functioning). According to Porter, health outcomes should be 
measured by medical condition (e.g., cancer), not by specialty 
(e.g., oncology) or intervention (e.g., chemotherapy). More 
importantly, health outcomes should be considered across the 
full period of care for the condition and should track the patient’s 
health status after conclusion of care (23).
In practice, the consideration of health outcomes, including 
HRQOL, represents only one tier for the development of an 
effective valued-based system in health care. Other tiers may 
include the development of (1) integrated health-care practice 
units comprising clinical and non-clinical health-care team 
members; (2) bundled payment systems that cover the full care 
cycle over a defined period of time or for a defined population, 
based on improvement of health outcomes; (3) integrated care 
delivery systems able to eliminate fragmentation of care; and 
(4)  local network opportunities among clinics and medical 
institutions (24). All of these practical proposals may favor a 
change from the evidence-based model (centered purely on 
scientific evidence and organized around what physicians do) 
to a valued-based model (centered on the patient and organized 
around what patients need) (23, 24). The value-based medicine 
model seems to comply with the definition of health reported 
by the World Health Organization (WHO): “Health is a state of 
complete physical, mental, and social well-being and not merely 
the absence of disease or infirmity” (25).
Health outcomes measure the effects of treatment and care 
that patients receive. Outcomes include, for example, remission 
of the condition, degree of patient functionality, recovery status, 
and emotional well-being. The value-based medicine model 
highlights the importance of the psycho-social dimensions, 
which enrich the traditional clinical picture by describing the 
patient not only as sick but also a person with a specific biophysi-
cal and psychological profile who is inserted in a social context 
(family, work, etc.). The direction proposed by value-based 
medicine indicates that hospitals need to place the patient in the 
center, evaluating and integrating all human and social aspects 
of a person.
According to this model, outcome indicators need to be appro-
priate and specific for each particular condition. They should not 
be measured for a single event or over a short time frame but 
rather should be measured throughout the entire course of treat-
ment (e.g., inpatient, outpatient, and day hospital phases). This 
perspective advocates the importance of a personalized approach 
to medicine, particularly the Five Ps of Personalization, which 
includes a Predictive, Precise, Preventive, Participatory Medicine 
that is sensitive to Psychological aspects and the patient’s cognitive 
characteristics (26). In particular, consideration of the psycho-
logical aspects requires an investigation of the psycho-cognitive 
variables that come into play when each individual makes a 
personal choice (27–29) with respect to the health, treatment, 
and care pathways.
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